New England Journal of Medicine to Supremes: Uphold Vermont Ban on Selling MD Prescription Data to Big Pharma

An editorial in the New England Journal of Medicine calls on the U.S. Supreme Court to uphold the Vermont law that requires pharmaceutical data mining companies to obtain physician’s consent before selling their prescription data to drug companies. “This undesirable practice is nothing more than commercial conduct—not speech,” the editors wrote, “and it is not in the best interests of the American people.”